TIOTROPIUM BROMIDE AND OLODATEROL

TIOTROPIUM BROMIDE AND OLODATEROL was reported 5135 times

TIOTROPIUM BROMIDE AND OLODATEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE ATROPHY 2 0.1667
1 TESTICULAR OPERATION 4 0.0714
2 INFECTION TRANSMISSION VIA PERSONAL CONTACT 2 0.0513
3 DEVICE CALIBRATION FAILURE 2 0.0377
4 CARDIAC THERAPEUTIC PROCEDURE 2 0.0294
5 CARDIAC MONITORING 3 0.0246
6 ALPHA-1 ANTITRYPSIN DEFICIENCY 2 0.0227
7 OXYGEN SATURATION 5 0.0190
8 DACRYOCANALICULITIS 2 0.0169
9 DEPENDENCE ON OXYGEN THERAPY 8 0.0162
10 NIPPLE SWELLING 4 0.0159
11 CYSTIC LUNG DISEASE 2 0.0141
12 GENITOURINARY SYMPTOM 2 0.0110
13 PRODUCT DELIVERY MECHANISM ISSUE 56 0.0104
14 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
15 DOSE CALCULATION ERROR 5 0.0085
16 CATARACT OPERATION COMPLICATION 4 0.0079
17 HUMIDITY INTOLERANCE 3 0.0075
18 OXYGEN CONSUMPTION DECREASED 4 0.0066
19 ANOXIA 2 0.0057
20 SPUTUM INCREASED 11 0.0051
21 SPUTUM RETENTION 5 0.0050
22 INFUSION SITE SCAR 2 0.0045
23 HALO VISION 5 0.0044
24 DEVICE ELECTRICAL FINDING 3 0.0042
25 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 207 0.0040
26 SQUAMOUS CELL CARCINOMA OF LUNG 3 0.0039
27 COATING IN MOUTH 2 0.0037
28 TONGUE ERYTHEMA 3 0.0036
29 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 3 0.0036
30 DRUG DELIVERY SYSTEM ISSUE 7 0.0035
31 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
32 INFUSION SITE DISCHARGE 6 0.0034
33 RESPIRATION ABNORMAL 23 0.0033
34 CHRONIC RESPIRATORY FAILURE 4 0.0033
35 TESTICULAR SWELLING 4 0.0032
36 PULMONARY PAIN 9 0.0031
37 INFUSION SITE URTICARIA 2 0.0030
38 TONGUE COATED 5 0.0029
39 ANGULAR CHEILITIS 2 0.0029
40 FUNGAL OESOPHAGITIS 2 0.0028
41 PRODUCT NAME CONFUSION 3 0.0027
42 EMPHYSEMA 27 0.0027
43 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
44 CHROMATOPSIA 2 0.0026
45 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2 0.0026
46 ORAL MUCOSAL ERYTHEMA 4 0.0026
47 TONGUE HAEMORRHAGE 3 0.0026
48 CROUP INFECTIOUS 2 0.0025
49 OXYGEN CONSUMPTION INCREASED 6 0.0025
50 PRODUCT PACKAGING CONFUSION 6 0.0025
51 DYSCHROMATOPSIA 2 0.0024
52 NASAL PRURITUS 3 0.0024
53 TONGUE DISCOMFORT 10 0.0024
54 ENZYME LEVEL INCREASED 2 0.0024
55 INFUSION SITE DISCOLOURATION 2 0.0023
56 ABDOMINAL NEOPLASM 2 0.0022
57 PRODUCTIVE COUGH 107 0.0022
58 MYCOBACTERIUM AVIUM COMPLEX INFECTION 6 0.0022
59 TONGUE DRY 3 0.0022
60 IMMUNOGLOBULINS DECREASED 3 0.0022
61 INCISIONAL HERNIA 3 0.0022
62 RESPIRATORY TRACT CONGESTION 34 0.0021
63 CATHETER SITE SWELLING 2 0.0021
64 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
65 OXYGEN SATURATION ABNORMAL 6 0.0021
66 HYPERMETROPIA 2 0.0021
67 MULTIPLE ALLERGIES 16 0.0020
68 MYASTHENIA GRAVIS CRISIS 3 0.0020
69 OBSTRUCTION 8 0.0020
70 ORAL MUCOSAL EXFOLIATION 3 0.0020
71 DRY THROAT 20 0.0020
72 DYSPNOEA EXERTIONAL 74 0.0020
73 BREAST ABSCESS 2 0.0020
74 DRUG DELIVERY SYSTEM MALFUNCTION 10 0.0020
75 ACUTE RESPIRATORY FAILURE 37 0.0019
76 EXFOLIATIVE RASH 5 0.0019
77 TESTICULAR PAIN 6 0.0019
78 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
79 CHOKING 36 0.0018
80 SHOULDER FRACTURE 3 0.0018
81 CHOKING SENSATION 10 0.0018
82 OXYGEN SATURATION DECREASED 101 0.0018
83 TONGUE BLISTERING 4 0.0018
84 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
85 CANDIDA INFECTION 30 0.0018
86 HEART VALVE INCOMPETENCE 5 0.0017
87 LIP PAIN 5 0.0017
88 INFUSION SITE INFECTION 4 0.0017
89 SPINAL CORD INJURY 3 0.0017
90 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
91 INCISION SITE PAIN 2 0.0017
92 SEASONAL ALLERGY 24 0.0017
93 PULMONARY CONGESTION 22 0.0017
94 ORAL DISCOMFORT 23 0.0017
95 DYSPNOEA 934 0.0016
96 APHONIA 23 0.0016
97 INFUSION SITE WARMTH 2 0.0016
98 DEVICE INFUSION ISSUE 4 0.0016
99 FRACTURED SACRUM 2 0.0016
100 DYSPHONIA 93 0.0016
101 THROAT IRRITATION 70 0.0016
102 MOUTH SWELLING 9 0.0016
103 INFUSION SITE IRRITATION 2 0.0016
104 MOTION SICKNESS 3 0.0016
105 VOCAL CORD DISORDER 3 0.0015
106 COUGH 422 0.0015
107 CYSTITIS NONINFECTIVE 2 0.0015
108 CARBON DIOXIDE INCREASED 2 0.0015
109 ORAL FUNGAL INFECTION 4 0.0015
110 SECRETION DISCHARGE 18 0.0014
111 INCORRECT DOSAGE ADMINISTERED 7 0.0014
112 HOSPICE CARE 14 0.0014
113 PHARYNGEAL ERYTHEMA 3 0.0014
114 LUNG TRANSPLANT 5 0.0014
115 DEVICE POWER SOURCE ISSUE 4 0.0014
116 INFUSION SITE INDURATION 2 0.0013
117 PULMONARY MASS 20 0.0013
118 ABNORMAL LOSS OF WEIGHT 9 0.0013
119 INFUSION SITE PAIN 17 0.0013
120 DEVICE DELIVERY SYSTEM ISSUE 36 0.0013
121 PNEUMONIA BACTERIAL 12 0.0013
122 BRONCHIAL DISORDER 2 0.0013
123 PATELLA FRACTURE 3 0.0013
124 ORAL INFECTION 5 0.0013
125 PROSTATOMEGALY 5 0.0013
126 RETCHING 27 0.0013
127 VOLVULUS 3 0.0013
128 INTERMITTENT CLAUDICATION 2 0.0013
129 EXTRA DOSE ADMINISTERED 51 0.0013
130 URINE FLOW DECREASED 3 0.0013
131 PRODUCT QUALITY ISSUE 170 0.0013
132 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
133 PAINFUL RESPIRATION 3 0.0012
134 AORTIC VALVE DISEASE 2 0.0012
135 HEART RATE IRREGULAR 28 0.0012
136 LUNG NEOPLASM MALIGNANT 50 0.0012
137 INFUSION SITE HAEMORRHAGE 4 0.0012
138 WHEEZING 72 0.0012
139 HYPERVOLAEMIA 6 0.0012
140 NEAR DEATH EXPERIENCE 4 0.0012
141 EXPOSURE TO SARS-COV-2 2 0.0012
142 INCREASED BRONCHIAL SECRETION 3 0.0012
143 MACULAR DEGENERATION 14 0.0012
144 INCREASED UPPER AIRWAY SECRETION 6 0.0012
145 REGURGITATION 4 0.0012
146 MICTURITION DISORDER 4 0.0012
147 HYPOPNOEA 4 0.0012
148 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
149 FIBRIN D DIMER INCREASED 4 0.0011
150 CARDIAC ABLATION 2 0.0011
151 NASAL DRYNESS 7 0.0011
152 HAEMOGLOBIN INCREASED 5 0.0011
153 CONTRAST MEDIA ALLERGY 2 0.0011
154 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
155 CATHETER PLACEMENT 2 0.0011
156 PNEUMOTHORAX 17 0.0011
157 SPUTUM DISCOLOURED 10 0.0011
158 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
159 PARANASAL SINUS HYPERSECRETION 4 0.0010
160 DYSPNOEA AT REST 3 0.0010
161 NECK INJURY 3 0.0010
162 HYPOGEUSIA 2 0.0010
163 THORACIC VERTEBRAL FRACTURE 3 0.0010
164 OROPHARYNGEAL PAIN 93 0.0010
165 RESPIRATORY TRACT INFECTION 26 0.0010
166 LUNG ADENOCARCINOMA 3 0.0010
167 INTRACRANIAL ANEURYSM 4 0.0010
168 REBOUND ACID HYPERSECRETION 3 0.0010
169 CRANIOCEREBRAL INJURY 3 0.0010
170 DEVICE DEPOSIT ISSUE 2 0.0010
171 DEVICE MALFUNCTION 69 0.0010
172 MASTICATION DISORDER 3 0.0010
173 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
174 INTERNATIONAL NORMALISED RATIO FLUCTUATION 2 0.0010
175 DEVICE CONNECTION ISSUE 2 0.0009
176 EYE CONTUSION 2 0.0009
177 BRONCHITIS 70 0.0009
178 RHINORRHOEA 61 0.0009
179 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
180 HYPERPHOSPHATAEMIA 2 0.0009
181 DEVICE OPERATIONAL ISSUE 4 0.0009
182 CARDIAC FLUTTER 6 0.0009
183 DIZZINESS POSTURAL 9 0.0009
184 PRODUCT RESIDUE PRESENT 5 0.0009
185 INFUSION SITE BRUISING 2 0.0009
186 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
187 SINUS DISORDER 18 0.0009
188 MUSCULOSKELETAL CHEST PAIN 14 0.0009
189 OCULAR DISCOMFORT 10 0.0009
190 WRONG PRODUCT ADMINISTERED 6 0.0009
191 OROPHARYNGEAL DISCOMFORT 8 0.0009
192 BLOOD LOSS ANAEMIA 2 0.0009
193 GINGIVAL PAIN 7 0.0009
194 LUNG DISORDER 43 0.0009
195 ABDOMINAL HERNIA 4 0.0009
196 SKIN ATROPHY 5 0.0009
197 PULMONARY HYPERTENSION 18 0.0009
198 DRY MOUTH 70 0.0009
199 HYPOACUSIS 37 0.0009
200 NASAL CONGESTION 50 0.0008
201 INSURANCE ISSUE 13 0.0008
202 CHEST DISCOMFORT 87 0.0008
203 SPINAL COLUMN STENOSIS 4 0.0008
204 HAND FRACTURE 6 0.0008
205 SKIN ABRASION 4 0.0008
206 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
207 PRODUCT PACKAGING ISSUE 8 0.0008
208 BRONCHOSPASM 12 0.0008
209 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
210 PRODUCT DISPENSING ERROR 18 0.0008
211 CAROTID ARTERY OCCLUSION 3 0.0008
212 BREATH SOUNDS ABNORMAL 4 0.0008
213 MUSCLE STRAIN 7 0.0008
214 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
215 CARDIAC DYSFUNCTION 3 0.0008
216 PROTEIN TOTAL DECREASED 3 0.0008
217 INFUSION SITE SWELLING 5 0.0008
218 CORONARY ARTERIAL STENT INSERTION 4 0.0008
219 ANGLE CLOSURE GLAUCOMA 2 0.0008
220 CANCER PAIN 2 0.0008
221 URINARY RETENTION 26 0.0008
222 OESOPHAGEAL DISORDER 3 0.0008
223 ANAL INCONTINENCE 7 0.0008
224 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
225 INTENTIONAL DOSE OMISSION 22 0.0008
226 RHINOVIRUS INFECTION 3 0.0008
227 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
228 SENSITIVITY TO WEATHER CHANGE 4 0.0008
229 IDIOPATHIC PULMONARY FIBROSIS 3 0.0008
230 CEREBRAL ATROPHY 3 0.0008
231 ANIMAL BITE 2 0.0007
232 ALCOHOL ABUSE 2 0.0007
233 BRONCHIECTASIS 5 0.0007
234 BACK DISORDER 12 0.0007
235 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
236 FEELING JITTERY 14 0.0007
237 TRIGGER FINGER 3 0.0007
238 DYSURIA 27 0.0007
239 RIB FRACTURE 15 0.0007
240 CYSTIC FIBROSIS 4 0.0007
241 ORAL PAIN 16 0.0007
242 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
243 EAR INFECTION 19 0.0007
244 RIGHT VENTRICULAR FAILURE 5 0.0007
245 HALLUCINATIONS, MIXED 3 0.0007
246 DRUG TOLERANCE DECREASED 2 0.0007
247 INFUSION SITE ERYTHEMA 6 0.0007
248 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
249 INTERVERTEBRAL DISC DISORDER 3 0.0007
250 CARDIAC OPERATION 6 0.0007
251 NEOPLASM 8 0.0007
252 BLOOD MAGNESIUM DECREASED 6 0.0007
253 DEVICE ISSUE 62 0.0007
254 TONGUE DISORDER 5 0.0007
255 FEEDING DISORDER 14 0.0007
256 HYPERVENTILATION 4 0.0007
257 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
258 SKIN WARM 4 0.0007
259 URINE OUTPUT DECREASED 6 0.0007
260 ONYCHOMYCOSIS 3 0.0007
261 SPINAL OSTEOARTHRITIS 6 0.0007
262 SLEEP APNOEA SYNDROME 13 0.0007
263 HAEMOPTYSIS 19 0.0007
264 INTENTIONAL DEVICE MISUSE 3 0.0007
265 IMMUNOSUPPRESSION 6 0.0007
266 DECREASED INTEREST 4 0.0007
267 PULMONARY FIBROSIS 13 0.0007
268 POST PROCEDURAL COMPLICATION 13 0.0007
269 CATHETERISATION CARDIAC 3 0.0007
270 PNEUMONIA 218 0.0007
271 ATYPICAL PNEUMONIA 2 0.0007
272 BLOOD CULTURE POSITIVE 2 0.0007
273 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
274 EYE INJURY 2 0.0007
275 DEVICE FAILURE 10 0.0007
276 CATARACT 39 0.0007
277 LUMBAR VERTEBRAL FRACTURE 3 0.0007
278 HIP FRACTURE 21 0.0007
279 EYE OPERATION 3 0.0007
280 NERVOUSNESS 34 0.0007
281 LOCALISED OEDEMA 3 0.0006
282 NEPHROGENIC ANAEMIA 3 0.0006
283 PRODUCT DISTRIBUTION ISSUE 6 0.0006
284 RENAL FUNCTION TEST ABNORMAL 3 0.0006
285 SKIN LACERATION 7 0.0006
286 INFUSION SITE EXTRAVASATION 4 0.0006
287 URINARY INCONTINENCE 19 0.0006
288 TASTE DISORDER 13 0.0006
289 ILLNESS 66 0.0006
290 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
291 FOOT FRACTURE 12 0.0006
292 IMPAIRED QUALITY OF LIFE 9 0.0006
293 BLOOD DISORDER 5 0.0006
294 GLAUCOMA 12 0.0006
295 EYE INFECTION 7 0.0006
296 PRODUCT PREPARATION ISSUE 4 0.0006
297 HICCUPS 5 0.0006
298 STAPHYLOCOCCAL SEPSIS 3 0.0006
299 ORAL CANDIDIASIS 8 0.0006
300 INTENTIONAL PRODUCT USE ISSUE 53 0.0006
301 CORONAVIRUS INFECTION 4 0.0006
302 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
303 EXPIRED DEVICE USED 2 0.0006
304 RESPIRATORY DISORDER 18 0.0006
305 POLLAKIURIA 25 0.0006
306 HYPOAESTHESIA ORAL 9 0.0006
307 HEART RATE INCREASED 59 0.0006
308 SINUS CONGESTION 8 0.0006
309 INFLUENZA 66 0.0006
310 TOOTH ABSCESS 6 0.0006
311 HEPATIC CYST 2 0.0006
312 SINUSITIS 60 0.0006
313 BLOOD SODIUM DECREASED 11 0.0006
314 PERIPHERAL VASCULAR DISORDER 3 0.0006
315 MUSCULOSKELETAL DISCOMFORT 10 0.0006
316 SNEEZING 13 0.0006
317 LARGE INTESTINE POLYP 4 0.0006
318 AORTIC STENOSIS 2 0.0006
319 BRAIN FOG 9 0.0006
320 CARDIOMEGALY 7 0.0006
321 EMBOLIC STROKE 2 0.0006
322 HYPOXIA 20 0.0006
323 ASTHMA 64 0.0006
324 EAR PAIN 11 0.0006
325 BLOOD POTASSIUM DECREASED 17 0.0006
326 ATRIAL FIBRILLATION 55 0.0006
327 GLOSSITIS 2 0.0006
328 RESPIRATORY RATE INCREASED 5 0.0006
329 DIVERTICULUM 4 0.0006
330 FACIAL PAIN 5 0.0006
331 HEREDITARY ANGIOEDEMA 6 0.0006
332 GASTROINTESTINAL INFECTION 5 0.0006
333 DECREASED ACTIVITY 6 0.0006
334 UPPER LIMB FRACTURE 11 0.0006
335 HYDROCEPHALUS 3 0.0006
336 FLUID RETENTION 28 0.0005
337 ORAL DISORDER 4 0.0005
338 PROSTATIC DISORDER 3 0.0005
339 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
340 HEART RATE ABNORMAL 3 0.0005
341 NEPHROPATHY 5 0.0005
342 CARDIAC FAILURE CONGESTIVE 43 0.0005
343 EPISTAXIS 40 0.0005
344 CHEST PAIN 99 0.0005
345 THERAPY NON-RESPONDER 24 0.0005
346 CHRONIC SINUSITIS 2 0.0005
347 PERIPHERAL SWELLING 82 0.0005
348 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
349 CHEMOTHERAPY 2 0.0005
350 FACE INJURY 2 0.0005
351 VENTRICULAR SEPTAL DEFECT 3 0.0005
352 DRUG EFFECT INCOMPLETE 19 0.0005
353 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
354 EXERCISE TOLERANCE DECREASED 3 0.0005
355 ATRIOVENTRICULAR BLOCK 4 0.0005
356 HERNIA 10 0.0005
357 PRODUCT TASTE ABNORMAL 7 0.0005
358 CONCUSSION 4 0.0005
359 BACK PAIN 120 0.0005
360 FAECES HARD 2 0.0005
361 PULMONARY OEDEMA 23 0.0005
362 PHARYNGEAL SWELLING 5 0.0005
363 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
364 COVID-19 PNEUMONIA 6 0.0005
365 PLEURISY 3 0.0005
366 THERAPY INTERRUPTED 36 0.0005
367 RENAL CYST 4 0.0005
368 BLADDER DISORDER 5 0.0005
369 SCIATICA 8 0.0005
370 COVID-19 88 0.0005
371 BLEPHARITIS 2 0.0005
372 POOR QUALITY DEVICE USED 5 0.0005
373 URINARY TRACT INFECTION 85 0.0005
374 EYE PAIN 28 0.0005
375 STENT PLACEMENT 4 0.0005
376 INJECTION SITE VESICLES 3 0.0005
377 PRODUCT PHYSICAL ISSUE 10 0.0005
378 FUNGAL SKIN INFECTION 2 0.0005
379 MYASTHENIA GRAVIS 4 0.0005
380 INITIAL INSOMNIA 5 0.0005
381 EAR DISCOMFORT 5 0.0005
382 EYE DISORDER 16 0.0005
383 SPINAL COMPRESSION FRACTURE 4 0.0005
384 POOR VENOUS ACCESS 5 0.0005
385 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
386 EYE DISCHARGE 5 0.0005
387 THROAT TIGHTNESS 13 0.0005
388 PRE-EXISTING CONDITION IMPROVED 3 0.0005
389 GAIT INABILITY 16 0.0005
390 WEIGHT FLUCTUATION 5 0.0005
391 PRODUCT ODOUR ABNORMAL 5 0.0005
392 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
393 PHOTOPSIA 3 0.0005
394 SCRATCH 5 0.0005
395 PRODUCT COMPLAINT 12 0.0005
396 THERAPEUTIC RESPONSE CHANGED 3 0.0005
397 RENAL PAIN 5 0.0005
398 HEPATIC PAIN 2 0.0005
399 PRODUCT CONTAINER ISSUE 4 0.0005
400 BONE CANCER 2 0.0005
401 PULMONARY THROMBOSIS 5 0.0005
402 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
403 GROIN PAIN 4 0.0005
404 IMMUNE SYSTEM DISORDER 6 0.0005
405 LOCALISED INFECTION 11 0.0005
406 APPETITE DISORDER 3 0.0005
407 RESPIRATORY FAILURE 33 0.0005
408 LIMB DISCOMFORT 14 0.0005
409 BLOOD CREATINE INCREASED 2 0.0005
410 MEDICATION ERROR 25 0.0004
411 TERMINAL STATE 3 0.0004
412 SWOLLEN TONGUE 14 0.0004
413 ILEUS PARALYTIC 2 0.0004
414 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
415 MALNUTRITION 5 0.0004
416 GOUT 8 0.0004
417 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
418 PLEURAL EFFUSION 27 0.0004
419 ULCER HAEMORRHAGE 3 0.0004
420 GASTROENTERITIS VIRAL 8 0.0004
421 PRODUCT DOSE OMISSION ISSUE 130 0.0004
422 SPEECH DISORDER 23 0.0004
423 EYE MOVEMENT DISORDER 3 0.0004
424 INTERNAL HAEMORRHAGE 5 0.0004
425 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
426 MUSCLE SPASMS 79 0.0004
427 VISION BLURRED 59 0.0004
428 HEPATIC STEATOSIS 8 0.0004
429 FEELING OF DESPAIR 2 0.0004
430 DEFAECATION URGENCY 3 0.0004
431 DIARRHOEA HAEMORRHAGIC 4 0.0004
432 CARDIAC DISORDER 40 0.0004
433 BLOOD TEST ABNORMAL 6 0.0004
434 UNEVALUABLE EVENT 32 0.0004
435 ARTHRITIS 33 0.0004
436 HYPERSOMNIA 12 0.0004
437 ANHEDONIA 11 0.0004
438 WRIST FRACTURE 5 0.0004
439 PARAESTHESIA ORAL 6 0.0004
440 TREMOR 69 0.0004
441 PANIC REACTION 3 0.0004
442 VISUAL FIELD DEFECT 3 0.0004
443 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
444 FALL 137 0.0004
445 ORAL HERPES 8 0.0004
446 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
447 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
448 CEREBRAL DISORDER 3 0.0004
449 LIGAMENT SPRAIN 4 0.0004
450 VISUAL IMPAIRMENT 50 0.0004
451 GLOSSODYNIA 9 0.0004
452 APPLICATION SITE SWELLING 2 0.0004
453 DRY EYE 20 0.0004
454 SPINAL FRACTURE 8 0.0004
455 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
456 DIVERTICULITIS 11 0.0004
457 CELLULITIS 20 0.0004
458 PRODUCT ADMINISTRATION ERROR 8 0.0004
459 WEIGHT DECREASED 110 0.0004
460 BOWEL MOVEMENT IRREGULARITY 3 0.0004
461 HEADACHE 245 0.0004
462 VIRAL INFECTION 13 0.0004
463 LIP SWELLING 13 0.0004
464 THERAPY CESSATION 20 0.0004
465 NEOPLASM MALIGNANT 26 0.0004
466 PERICARDIAL EFFUSION 9 0.0004
467 CACHEXIA 2 0.0004
468 PAIN IN JAW 11 0.0004
469 HIATUS HERNIA 5 0.0004
470 PELVIC FRACTURE 3 0.0004
471 FAILURE TO THRIVE 2 0.0004
472 VENTRICULAR EXTRASYSTOLES 4 0.0004
473 DIZZINESS 192 0.0004
474 TRANSFUSION 4 0.0004
475 HALLUCINATION, VISUAL 8 0.0004
476 NASAL DISCOMFORT 3 0.0004
477 PRODUCT PRESCRIBING ERROR 9 0.0004
478 NECK PAIN 21 0.0004
479 EATING DISORDER 8 0.0004
480 BODY HEIGHT DECREASED 4 0.0004
481 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
482 COMPRESSION FRACTURE 2 0.0004
483 ASTHENIA 140 0.0004
484 RASH MACULAR 13 0.0004
485 POOR QUALITY SLEEP 8 0.0004
486 INTESTINAL OBSTRUCTION 14 0.0004
487 MENTAL IMPAIRMENT 9 0.0004
488 FRUSTRATION TOLERANCE DECREASED 3 0.0004
489 GINGIVITIS 2 0.0004
490 NEPHROLITHIASIS 17 0.0004
491 MUSCLE DISORDER 3 0.0004
492 BLOOD POTASSIUM INCREASED 6 0.0004
493 FAECES DISCOLOURED 8 0.0004
494 OEDEMA 20 0.0004
495 SHOCK HAEMORRHAGIC 3 0.0004
496 DECUBITUS ULCER 3 0.0004
497 BACK INJURY 4 0.0004
498 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
499 ABNORMAL FAECES 3 0.0004
500 MEMORY IMPAIRMENT 50 0.0004
501 ASTHENOPIA 2 0.0004
502 DEAFNESS UNILATERAL 2 0.0004
503 TOOTH FRACTURE 4 0.0004
504 RESPIRATORY DISTRESS 10 0.0004
505 GASTRIC ULCER HAEMORRHAGE 2 0.0004
506 MUSCULAR WEAKNESS 41 0.0004
507 DEMENTIA 10 0.0004
508 PANIC ATTACK 13 0.0004
509 SENSATION OF FOREIGN BODY 3 0.0004
510 INTENTIONAL PRODUCT MISUSE 31 0.0004
511 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
512 HYPOPHAGIA 9 0.0004
513 VITAMIN D DECREASED 3 0.0004
514 MICTURITION URGENCY 4 0.0003
515 PSEUDOMONAS INFECTION 3 0.0003
516 CORONARY ARTERY BYPASS 2 0.0003
517 OFF LABEL USE 304 0.0003
518 DEVICE DEFECTIVE 6 0.0003
519 BLOOD PRESSURE DECREASED 23 0.0003
520 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
521 ELECTROLYTE IMBALANCE 4 0.0003
522 DEVICE USE ISSUE 6 0.0003
523 GRIP STRENGTH DECREASED 3 0.0003
524 SEPSIS 38 0.0003
525 LUNG INFILTRATION 3 0.0003
526 DIARRHOEA 219 0.0003
527 ENERGY INCREASED 2 0.0003
528 BRADYKINESIA 2 0.0003
529 BLOOD IRON DECREASED 4 0.0003
530 CATARACT OPERATION 2 0.0003
531 IMMUNODEFICIENCY 5 0.0003
532 HYPERLIPIDAEMIA 4 0.0003
533 BLOOD PRESSURE FLUCTUATION 8 0.0003
534 GANGRENE 2 0.0003
535 LEUKOCYTOSIS 6 0.0003
536 LIMB INJURY 9 0.0003
537 PNEUMONITIS 9 0.0003
538 LIP DRY 3 0.0003
539 BLOOD COUNT ABNORMAL 5 0.0003
540 NOCTURIA 4 0.0003
541 OSTEOPENIA 5 0.0003
542 INGUINAL HERNIA 2 0.0003
543 SKIN DISCOLOURATION 15 0.0003
544 FATIGUE 254 0.0003
545 FEELING ABNORMAL 78 0.0003
546 SPINAL OPERATION 4 0.0003
547 THYROID DISORDER 5 0.0003
548 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
549 LYMPHOMA 5 0.0003
550 BACTERIAL INFECTION 6 0.0003
551 HEPATIC ENCEPHALOPATHY 3 0.0003
552 MIDDLE INSOMNIA 6 0.0003
553 APPENDICITIS 3 0.0003
554 SWELLING 30 0.0003
555 FLANK PAIN 3 0.0003
556 PRODUCT USE COMPLAINT 5 0.0003
557 DEVICE USE ERROR 11 0.0003
558 HYPERTENSION 67 0.0003
559 HEAD INJURY 10 0.0003
560 PALPITATIONS 37 0.0003
561 NASOPHARYNGITIS 58 0.0003
562 RASH PRURITIC 17 0.0003
563 HEART RATE DECREASED 11 0.0003
564 LOWER LIMB FRACTURE 6 0.0003
565 LOSS OF CONSCIOUSNESS 40 0.0003
566 ROAD TRAFFIC ACCIDENT 13 0.0003
567 ATELECTASIS 3 0.0003
568 HERPES SIMPLEX 2 0.0003
569 PLATELET COUNT INCREASED 4 0.0003
570 KIDNEY INFECTION 6 0.0003
571 ANXIETY 87 0.0003
572 DYSPHAGIA 29 0.0003
573 VITREOUS FLOATERS 3 0.0003
574 TINNITUS 14 0.0003
575 METASTASES TO BONE 5 0.0003
576 TOOTH INFECTION 4 0.0003
577 CHRONIC KIDNEY DISEASE 23 0.0003
578 CARDIAC FAILURE ACUTE 2 0.0003
579 EYE HAEMORRHAGE 4 0.0003
580 BRAIN INJURY 3 0.0003
581 LACRIMATION INCREASED 9 0.0003
582 BREAST MASS 2 0.0003
583 SLEEP DISORDER 21 0.0003
584 LETHARGY 17 0.0003
585 OCULAR HYPERAEMIA 14 0.0003
586 BLOOD PRESSURE INCREASED 45 0.0003
587 TACHYPNOEA 4 0.0003
588 IMPAIRED GASTRIC EMPTYING 4 0.0003
589 GINGIVAL BLEEDING 4 0.0003
590 SWELLING FACE 19 0.0003
591 DEVICE MECHANICAL ISSUE 4 0.0003
592 OSTEOPOROSIS 12 0.0003
593 TEMPERATURE INTOLERANCE 3 0.0003
594 PRODUCT USE IN UNAPPROVED INDICATION 72 0.0003
595 INFECTION 42 0.0003
596 CHILLS 34 0.0003
597 PROCEDURAL PAIN 8 0.0003
598 TENDERNESS 3 0.0003
599 PETECHIAE 3 0.0003
600 GAIT DISTURBANCE 55 0.0003
601 FEELING COLD 8 0.0003
602 HUNGER 4 0.0003
603 EXTRASYSTOLES 2 0.0003
604 WOUND 8 0.0003
605 DEHYDRATION 38 0.0003
606 DYSPEPSIA 28 0.0003
607 DECREASED APPETITE 66 0.0003
608 PRODUCT USE ISSUE 53 0.0003
609 AGEUSIA 7 0.0003
610 CONTUSION 27 0.0003
611 MALAISE 123 0.0003
612 STOMATITIS 17 0.0003
613 BREAST CANCER METASTATIC 3 0.0003
614 RENAL DISORDER 13 0.0003
615 CARDIAC ARREST 23 0.0003
616 ABDOMINAL DISTENSION 29 0.0003
617 PRURITUS GENERALISED 6 0.0003
618 DRY SKIN 37 0.0003
619 ANOSMIA 4 0.0003
620 TOOTHACHE 5 0.0003
621 BIPOLAR DISORDER 3 0.0003
622 HYPOKINESIA 4 0.0003
623 PRODUCT PRESCRIBING ISSUE 6 0.0003
624 FAECES SOFT 2 0.0003
625 ABDOMINAL DISCOMFORT 46 0.0003
626 END STAGE RENAL DISEASE 5 0.0003
627 INSOMNIA 73 0.0003
628 INTENTIONAL UNDERDOSE 2 0.0003
629 BLINDNESS TRANSIENT 2 0.0003
630 DENTAL CARIES 3 0.0003
631 BLOOD GLUCOSE ABNORMAL 5 0.0003
632 CONSTIPATION 59 0.0003
633 TOOTH DISORDER 6 0.0003
634 DIPLOPIA 7 0.0003
635 DRUG INTOLERANCE 26 0.0003
636 EYE SWELLING 10 0.0003
637 SKIN INFECTION 3 0.0003
638 INTESTINAL PERFORATION 3 0.0003
639 MUSCULOSKELETAL PAIN 14 0.0003
640 DEATH 230 0.0003
641 HEPATIC CIRRHOSIS 5 0.0003
642 PAIN IN EXTREMITY 78 0.0003
643 ECONOMIC PROBLEM 4 0.0003
644 IMPAIRED DRIVING ABILITY 3 0.0003
645 AORTIC ANEURYSM 2 0.0003
646 VERTIGO 16 0.0003
647 DRUG INEFFECTIVE 345 0.0003
648 DRUG DISPENSING ERROR 4 0.0003
649 HERPES ZOSTER 15 0.0003
650 HOSPITALISATION 40 0.0003
651 FEAR 7 0.0003
652 CEREBROVASCULAR ACCIDENT 44 0.0003
653 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
654 HYPOTENSION 52 0.0003
655 POST PROCEDURAL HAEMORRHAGE 3 0.0003
656 LUNG INFECTION 4 0.0003
657 BURNING SENSATION 18 0.0003
658 HAEMORRHAGIC STROKE 2 0.0003
659 BONE PAIN 15 0.0003
660 SPINAL PAIN 3 0.0003
661 SKIN FISSURES 5 0.0003
662 BALANCE DISORDER 22 0.0003
663 NEUROPATHY PERIPHERAL 24 0.0003
664 BLOOD ALBUMIN DECREASED 2 0.0003
665 BLOOD PRESSURE ABNORMAL 5 0.0003
666 ULCER 4 0.0003
667 MIGRAINE 24 0.0003
668 ACCIDENT 3 0.0003
669 ATRIAL FLUTTER 2 0.0003
670 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
671 MOVEMENT DISORDER 8 0.0002
672 PRESYNCOPE 6 0.0002
673 FEELING HOT 15 0.0002
674 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
675 NAUSEA 193 0.0002
676 SMALL INTESTINAL OBSTRUCTION 3 0.0002
677 STAPHYLOCOCCAL INFECTION 8 0.0002
678 DYSGEUSIA 18 0.0002
679 PHARYNGITIS 3 0.0002
680 CYST 3 0.0002
681 JOINT SWELLING 29 0.0002
682 FUNGAL INFECTION 8 0.0002
683 ATRIAL SEPTAL DEFECT 2 0.0002
684 SURGERY 14 0.0002
685 ABDOMINAL PAIN UPPER 49 0.0002
686 HAEMATEMESIS 6 0.0002
687 MOBILITY DECREASED 17 0.0002
688 TACHYCARDIA 21 0.0002
689 HAEMATOCHEZIA 13 0.0002
690 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11 0.0002
691 INTRAOCULAR PRESSURE INCREASED 3 0.0002
692 SOMNOLENCE 47 0.0002
693 UNRESPONSIVE TO STIMULI 6 0.0002
694 SKIN CANCER 5 0.0002
695 CARDIAC MURMUR 2 0.0002
696 DEVICE LEAKAGE 10 0.0002
697 ILL-DEFINED DISORDER 14 0.0002
698 RASH ERYTHEMATOUS 11 0.0002
699 NODULE 3 0.0002
700 DRUG DOSE OMISSION BY DEVICE 18 0.0002
701 OEDEMA PERIPHERAL 28 0.0002
702 MYOCARDIAL INFARCTION 40 0.0002
703 FLATULENCE 13 0.0002
704 BLOOD GLUCOSE DECREASED 11 0.0002
705 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
706 BEDRIDDEN 3 0.0002
707 HYPOAESTHESIA 34 0.0002
708 COLD SWEAT 4 0.0002
709 ADVERSE REACTION 3 0.0002
710 HEAD DISCOMFORT 4 0.0002
711 EYE IRRITATION 13 0.0002
712 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
713 MALIGNANT MELANOMA 3 0.0002
714 THIRST 4 0.0002
715 DIABETES MELLITUS 17 0.0002
716 ADVERSE DRUG REACTION 20 0.0002
717 DISTURBANCE IN ATTENTION 12 0.0002
718 CONDITION AGGRAVATED 67 0.0002
719 DEPRESSION 50 0.0002
720 HIDRADENITIS 2 0.0002
721 CORONARY ARTERY OCCLUSION 3 0.0002
722 INFLUENZA LIKE ILLNESS 18 0.0002
723 PERIPHERAL COLDNESS 3 0.0002
724 PAIN 134 0.0002
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
726 BRAIN NEOPLASM 2 0.0002
727 INCREASED TENDENCY TO BRUISE 2 0.0002
728 NIGHT SWEATS 7 0.0002
729 IRON DEFICIENCY ANAEMIA 2 0.0002
730 AMNESIA 14 0.0002
731 MASS 3 0.0002
732 DEVICE OCCLUSION 3 0.0002
733 BLINDNESS UNILATERAL 3 0.0002
734 CARDIAC FAILURE 17 0.0002
735 FRACTURE 4 0.0002
736 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
737 BLOOD URINE PRESENT 4 0.0002
738 GASTRIC ULCER 4 0.0002
739 WEIGHT INCREASED 47 0.0002
740 SYNCOPE 21 0.0002
741 RED BLOOD CELL COUNT DECREASED 6 0.0002
742 SUBDURAL HAEMATOMA 3 0.0002
743 INCREASED APPETITE 4 0.0002
744 EYE PRURITUS 7 0.0002
745 FLUID OVERLOAD 3 0.0002
746 HAEMORRHOIDS 4 0.0002
747 CONFUSIONAL STATE 33 0.0002
748 ASCITES 6 0.0002
749 GASTRIC DISORDER 7 0.0002
750 HEPATOMEGALY 2 0.0002
751 CARDIOMYOPATHY 3 0.0002
752 INTENTIONAL OVERDOSE 13 0.0002
753 SKIN HAEMORRHAGE 3 0.0002
754 INCORRECT DOSE ADMINISTERED 46 0.0002
755 INABILITY TO AFFORD MEDICATION 2 0.0002
756 GASTROINTESTINAL DISORDER 18 0.0002
757 THROMBOSIS 16 0.0002
758 CORONARY ARTERY DISEASE 6 0.0002
759 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
760 ARTHRALGIA 82 0.0002
761 HIP ARTHROPLASTY 3 0.0002
762 EUPHORIC MOOD 2 0.0002
763 HELICOBACTER INFECTION 2 0.0002
764 ERYTHEMA 40 0.0002
765 ANKLE FRACTURE 3 0.0002
766 TENDONITIS 3 0.0002
767 SKIN ULCER 5 0.0002
768 DELUSION 3 0.0002
769 THERAPY PARTIAL RESPONDER 3 0.0002
770 VOMITING 90 0.0002
771 ACCIDENTAL OVERDOSE 7 0.0002
772 DEAFNESS 5 0.0002
773 CYANOSIS 3 0.0002
774 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
775 AGITATION 14 0.0002
776 SKIN EXFOLIATION 16 0.0002
777 INCONTINENCE 2 0.0002
778 JOINT DISLOCATION 2 0.0002
779 OSTEOARTHRITIS 8 0.0002
780 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
781 BREAST PAIN 2 0.0002
782 PRURITUS 72 0.0002
783 JOINT INJURY 4 0.0002
784 FLUSHING 19 0.0002
785 IRRITABLE BOWEL SYNDROME 4 0.0002
786 HYPERHIDROSIS 24 0.0002
787 RECTAL HAEMORRHAGE 8 0.0002
788 MUSCLE TIGHTNESS 3 0.0002
789 FREQUENT BOWEL MOVEMENTS 5 0.0002
790 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
791 PARAESTHESIA 29 0.0002
792 ANAEMIA 35 0.0002
793 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
794 VENTRICULAR TACHYCARDIA 3 0.0002
795 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
796 RESPIRATORY ARREST 5 0.0002
797 ABNORMAL DREAMS 5 0.0002
798 FOOT DEFORMITY 2 0.0002
799 LIVER DISORDER 8 0.0002
800 DISCOMFORT 11 0.0002
801 HYPERTENSIVE CRISIS 2 0.0002
802 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
803 BLISTER 10 0.0002
804 BLOOD CALCIUM DECREASED 2 0.0002
805 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
806 CHROMATURIA 4 0.0002
807 APPLICATION SITE PRURITUS 4 0.0002
808 PYREXIA 61 0.0002
809 DERMATITIS CONTACT 2 0.0002
810 CHOLECYSTECTOMY 2 0.0002
811 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
812 ANGINA PECTORIS 5 0.0002
813 URTICARIA 29 0.0002
814 NEOPLASM PROGRESSION 6 0.0002
815 HOT FLUSH 13 0.0002
816 BLINDNESS 7 0.0002
817 METASTASES TO LIVER 3 0.0002
818 LYMPHADENOPATHY 6 0.0002
819 LABORATORY TEST ABNORMAL 5 0.0002
820 ISCHAEMIC STROKE 3 0.0002
821 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
822 RENAL FAILURE 22 0.0002
823 INTERSTITIAL LUNG DISEASE 8 0.0002
824 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
825 RESTLESS LEGS SYNDROME 3 0.0002
826 BURSITIS 2 0.0002
827 MYALGIA 28 0.0002
828 BONE DISORDER 3 0.0002
829 NEURALGIA 4 0.0002
830 ACUTE KIDNEY INJURY 25 0.0002
831 ALOPECIA 32 0.0002
832 ANAPHYLACTIC REACTION 9 0.0002
833 HYPERCALCAEMIA 2 0.0002
834 ABNORMAL WEIGHT GAIN 2 0.0002
835 APPLICATION SITE IRRITATION 2 0.0002
836 HAIR COLOUR CHANGES 2 0.0002
837 PNEUMONIA ASPIRATION 4 0.0002
838 BONE DENSITY DECREASED 5 0.0002
839 PHOTOPHOBIA 3 0.0002
840 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
841 ABDOMINAL PAIN LOWER 4 0.0002
842 GASTRIC CANCER 4 0.0002
843 ANAPHYLACTIC SHOCK 4 0.0002
844 ERUCTATION 3 0.0002
845 EXPOSURE VIA SKIN CONTACT 4 0.0002
846 HAEMORRHAGE 16 0.0002
847 CHOLELITHIASIS 5 0.0002
848 ADVERSE EVENT 14 0.0002
849 DISABILITY 3 0.0002
850 DISORIENTATION 6 0.0002
851 DEPRESSED MOOD 8 0.0002
852 HAEMATOCRIT DECREASED 3 0.0002
853 HYPERSENSITIVITY 28 0.0002
854 BREAST CANCER FEMALE 4 0.0001
855 RASH 65 0.0001
856 FULL BLOOD COUNT DECREASED 3 0.0001
857 BLOOD BILIRUBIN INCREASED 4 0.0001
858 ANGER 5 0.0001
859 BODY TEMPERATURE INCREASED 3 0.0001
860 HEPATIC ENZYME INCREASED 10 0.0001
861 ABDOMINAL PAIN 34 0.0001
862 PRODUCT PREPARATION ERROR 3 0.0001
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
864 NIGHTMARE 5 0.0001
865 MENTAL STATUS CHANGES 4 0.0001
866 DERMATITIS 3 0.0001
867 CARPAL TUNNEL SYNDROME 2 0.0001
868 ACCIDENTAL UNDERDOSE 2 0.0001
869 DEEP VEIN THROMBOSIS 9 0.0001
870 INJECTION SITE BRUISING 11 0.0001
871 MENTAL DISORDER 6 0.0001
872 PRODUCT DOSE OMISSION 9 0.0001
873 CRYING 5 0.0001
874 HYPERGLYCAEMIA 5 0.0001
875 DYSSTASIA 4 0.0001
876 MUSCULOSKELETAL STIFFNESS 12 0.0001
877 HAEMOGLOBIN DECREASED 14 0.0001
878 DEVICE DIFFICULT TO USE 9 0.0001
879 RASH PAPULAR 3 0.0001
880 DYSARTHRIA 5 0.0001
881 PRODUCT AVAILABILITY ISSUE 3 0.0001
882 INJECTION SITE RASH 4 0.0001
883 GYNAECOMASTIA 4 0.0001
884 FEMUR FRACTURE 4 0.0001
885 COGNITIVE DISORDER 6 0.0001
886 BASAL CELL CARCINOMA 2 0.0001
887 PLASMA CELL MYELOMA 5 0.0001
888 TREATMENT NONCOMPLIANCE 7 0.0001
889 PULMONARY EMBOLISM 12 0.0001
890 HALLUCINATION, AUDITORY 2 0.0001
891 PRODUCT STORAGE ERROR 11 0.0001
892 CYSTITIS 4 0.0001
893 MOOD SWINGS 4 0.0001
894 HYPONATRAEMIA 7 0.0001
895 HYPOGLYCAEMIA 6 0.0001
896 FIBROMYALGIA 3 0.0001
897 DEVICE BREAKAGE 5 0.0001
898 DYSKINESIA 5 0.0001
899 BLOOD CREATININE INCREASED 8 0.0001
900 ENCEPHALOPATHY 3 0.0001
901 BLOOD GLUCOSE INCREASED 23 0.0001
902 SEIZURE 14 0.0001
903 DRUG LEVEL INCREASED 2 0.0001
904 EXPIRED PRODUCT ADMINISTERED 4 0.0001
905 HALLUCINATION 9 0.0001
906 RENAL IMPAIRMENT 10 0.0001
907 CARDIOVASCULAR DISORDER 3 0.0001
908 HAEMATURIA 4 0.0001
909 DRUG RESISTANCE 3 0.0001
910 IRRITABILITY 7 0.0001
911 EMOTIONAL DISTRESS 14 0.0001
912 DELIRIUM 4 0.0001
913 APPLICATION SITE ERYTHEMA 3 0.0001
914 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
915 CEREBRAL HAEMORRHAGE 4 0.0001
916 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
917 DISEASE PROGRESSION 13 0.0001
918 UNDERDOSE 8 0.0001
919 HYPOKALAEMIA 5 0.0001
920 ARTHROPATHY 6 0.0001
921 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
922 HYPOCALCAEMIA 2 0.0001
923 INFUSION RELATED REACTION 7 0.0001
924 DISEASE RECURRENCE 5 0.0001
925 PRODUCT SUBSTITUTION ISSUE 6 0.0001
926 PANCREATIC CARCINOMA 3 0.0001
927 PLATELET COUNT DECREASED 11 0.0001
928 NEEDLE ISSUE 3 0.0001
929 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
930 PSYCHOTIC DISORDER 3 0.0001
931 RENAL INJURY 3 0.0001
932 SUICIDAL IDEATION 9 0.0001
933 EMOTIONAL DISORDER 3 0.0001
934 RHEUMATOID ARTHRITIS 11 0.0001
935 INFLAMMATION 5 0.0001
936 ECZEMA 5 0.0001
937 KNEE ARTHROPLASTY 2 0.0001
938 PANCREATITIS 5 0.0001
939 HYPOTHYROIDISM 3 0.0001
940 SEPTIC SHOCK 4 0.0001
941 IMPAIRED HEALING 3 0.0001
942 INJECTION SITE SWELLING 7 0.0001
943 INJECTION SITE PAIN 28 0.0001
944 APPLICATION SITE PAIN 2 0.0001
945 COLITIS ULCERATIVE 4 0.0001
946 OVERDOSE 19 0.0001
947 BREAST CANCER 8 0.0001
948 BLADDER CANCER 5 0.0001
949 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
950 ARRHYTHMIA 4 0.0001
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
952 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
953 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
954 THERAPEUTIC RESPONSE DECREASED 5 0.0001
955 INJECTION SITE URTICARIA 2 0.0001
956 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
957 COLITIS 3 0.0001
958 NO ADVERSE EVENT 14 0.0001
959 HAEMATOMA 2 0.0001
960 DRUG INTERACTION 12 0.0001
961 INJECTION SITE PRURITUS 5 0.0001
962 DRUG EFFECT DECREASED 4 0.0001
963 NEUTROPHIL COUNT DECREASED 3 0.0001
964 WITHDRAWAL SYNDROME 3 0.0001
965 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
966 ACUTE MYOCARDIAL INFARCTION 2 0.0001
967 HEPATIC FAILURE 2 0.0001
968 ACNE 5 0.0001
969 INJECTION SITE ERYTHEMA 8 0.0001
970 PROSTATE CANCER 5 0.0001
971 AGGRESSION 3 0.0001
972 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
973 INJECTION SITE REACTION 4 0.0001
974 HYPERKALAEMIA 2 0.0001
975 BRADYCARDIA 3 0.0001
976 PSORIASIS 7 0.0001
977 ABNORMAL BEHAVIOUR 2 0.0001
978 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
979 DRUG DOSE OMISSION 8 0.0000
980 DEVICE DISLOCATION 2 0.0000
981 THROMBOCYTOPENIA 5 0.0000
982 BLOOD CHOLESTEROL INCREASED 2 0.0000
983 COMA 2 0.0000
984 DERMATITIS ATOPIC 2 0.0000
985 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
986 TREATMENT FAILURE 3 0.0000
987 EXPOSURE DURING PREGNANCY 2 0.0000
988 NEUTROPENIA 4 0.0000
989 INJURY 2 0.0000
990 INJECTION SITE HAEMORRHAGE 2 0.0000